The treatment of people with HIV infection is rapidly and constantly progressing as new research findings become available. With more than 20 approved ARVs and 6 ARV classes, health care providers caring for HIV-positive patients have increasingly complex choices regarding ARV therapy for the management of treatment-naïve and treatment-experienced patients. While these choices provide health care providers and patients with important new options, they also lead to new challenges. For the health care provider treating HIV infection, it is very difficult to keep up with the rapidly increasing amount of new information that becomes available through journal articles, conference presentations, CME programs, and other sources. The availability and understanding of this constant stream of new research data and information is essential for providing the best possible ARV therapies and therapeutic strategies that are most likely to lead to successful and durable ARV therapy in ARV-naïve and ARV-experienced patients.
This online activity set in a talk show format, includes important new data that have been presented or published throughout 2011. Program topics discussed include When to Start and What to Start with HIV Treatment; Treatment as Prevention; Switching Guidelines; HCV-HIV Co-infection and Experimental HIV Therapies.
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.
This activity is supported by an unrestricted educational grant by Gilead Sciences.
Upon completion of the program, participants should be able to:
Outline current ARV drug options available for treatment-naïve patients with HIV based upon guideline recommendations and current clinical research;
Describe appropriate therapeutic strategies in the management of treatment-experienced patients with HIV;
Use information about drug adverse events, drug pharmacokinetics and patient adherence to achieve ARV success to avoid morbidity and mortality;
Describe preventive care for the important opportunistic infections and co-morbidities that may increase the risk for morbidity and mortality in HIV positive patients;
Describe the importance of individualizing the care of each HIV-positive patient in clinical practice.
Release Date: January 25, 2012
Expiration Date: January 25, 2013
Estimated time to complete this on-demand Web symposium: 2 hours
Media: Internet
| Calvin J. Cohen, MD, MS Research Director, CRI New England Clinical Instructor, Harvard Medical School Boston, Massachusetts |
Ian Frank, MD Associate Professor of Medicine, Director, Antiretroviral Clinical Research University of Pennsylvania Philadelphia, Pennsylvania |
| Judith Feinberg, MD Professor of Medicine, Associate Chair of Medicine for Faculty Development, University of Cincinnati College of Medicine Cincinnati, Ohio |
Richard A. Elion, MD Associate Professor of Clinical Medicine, George Washington University Medical Center Washington, DC |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine assesses conflicts of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Postgraduate Institute for Medicine is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
|
Calvin Cohen, MD, MS
|
|
Richard Elion, MD
|
|
Judith Feinberg, MD
|
|
Ian Frank, MD
|
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchinson, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine, ViralEd, Inc. and Gilead Sciences. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Postgraduate Institute for Medicine, ViralEd, Inc. and Gilead Sciences. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
You may complete the post-test online at: http://www.cmeuniversity.com/
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This program requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
 |
 |
